MedPath

Association of the Arteriovenous Difference in Carbon Dioxide and Its Relation to the Difference in Arteriovenous Oxygen Content With the Occurrence of Postoperative Complication

Completed
Conditions
Surgery--Complications
Interventions
Procedure: patient having to undergo a high risk programmed digestive surgery
Registration Number
NCT03914976
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Intra-operative hemodynamic management in high-risk surgery is a priority for the anesthesiologist. The current strategy is based on the continuous measurement of cardiac output and its maximization by vascular filling has many limitations: invasiveness, measurement difficulties, impaired performance, imperative surgical restriction of filling, lack of evaluation of flow rate and metabolic needs. Biomarkers may be able to detect early an inadequacy between cardiac output and tissue oxygen requirements, venous saturation with oxygen (ScvO2) and arteriovenous difference in partial pressure of carbon dioxide (ΔPCO2) as well as the appearance of cellular hypoxia (lactate and arteriovenous difference in partial pressure of carbon dioxide/arteriovenous difference in oxygen) (ΔPCO2) / DAVO2). Moreover, the medical literature remains poor on the evaluation of these markers in per-operative context all the more for ΔPCO2 and ΔPCO2 / DAVO2. It seems interesting to evaluate the potential of these tools, in patients with major surgery and at high risk (major hepatectomy, oesophagectomy and duodeno-pancreatectomy), to predict the risk of postoperative complications, especially since surgery involves a restrictive vascular filling strategy that may be potentially deleterious to the patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria

Major patient

Patient eligible for a high risk scheduled gastrointestinal surgery from:

  • Esophagectomy
  • Major hepatectomy (≥ 3 segments)
  • Cephalic duodeno-pancreatectomy Patient with an arterial catheter and a central venous line in superior vena cava.

Patient hospitalized post-operatively in intensive care unit as agreed in consultation with preoperative anesthesia.

Read More
Exclusion Criteria
  • Pregnant or lactating patients
  • Patient with an unstable acute condition at the time of surgery (acute heart, respiratory or renal failure, severe sepsis or septic shock, hemorrhagic shock)
  • Patient opposing his participation in the study
  • Patient protected by law (guardianship)
  • Patient deprived of liberty
  • Patient with a contraindication to the establishment of a central venous route in superior vena cava territory or a radial or femoral arterial catheter
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patient who will have a high risk digestive surgerypatient having to undergo a high risk programmed digestive surgerypatient who will have a high risk digestive surgery: esophagectomy, major hepatectomy\> 3 segments, duodeno cephalic pancreatectomy
Primary Outcome Measures
NameTimeMethod
mean intraoperative PCO2 valuesduring surgery

PCO2 values will be collected every 2 hours during surgery

mean postoperative PCO2 valueswithin 24 hours after surgery
post-operative complications28 days after surgery

post-operative complications of grade III or greater according to Clavien-Dindo classification

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital de la Croix Rousse

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath